comparemela.com

Latest Breaking News On - Shweta munjal - Page 1 : comparemela.com

Lupin : December 27, 2023 Lupin Receives Approval from U S FDA for Loteprednol Etabonate Ophthalmic Suspension, 0 2% -December 27, 2023 at 03:42 pm EST

Mumbai, Baltimore, December 27, 2023: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its.

United statesSouth africaAsia pacificShweta munjalBausch lomb incLupin limitedDrug administrationBiotechnology pharmaceuticalsCorporate communicationsUnited states foodAbbreviated new drug applicationLoteprednol etabonate ophthalmic suspensionOphthalmic suspensionEtabonate ophthalmic suspensionLatin americaMiddle east

Lupin : December 15, 2023 Lupin Receives Approval from U S FDA for Allopurinol Tablets -December 15, 2023 at 07:03 am EST

Mumbai, Baltimore, December 15,2023: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its.

United statesSouth africaShweta munjalAsia pacificCasper pharmaBiotechnology pharmaceuticalsDrug administrationCorporate communications sustainabilityLupin limitedUnited states foodAbbreviated new drug applicationAllopurinol tabletsZyloprim tabletsLatin americaMiddle eastGreat place

Lupin : December 15, 2023 Lupin Receives Tentative Approval from U S FDA for Sitagliptin Tablets -December 15, 2023 at 06:52 am EST

Mumbai, Baltimore, December 15, 2023: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration for.

South africaUnited statesAsia pacificShweta munjalDrug administrationCorporate communicationsLupin limitedDohme corpBiotechnology pharmaceuticalsUnited states foodAbbreviated new drug applicationSitagliptin tabletsJanuvia tabletsMerck sharpLatin americaMiddle east

Lupin : November 21, 2023 Lupin Receives Tentative Approval from U S FDA for Dapagliflozin Tablets -November 21, 2023 at 05:04 am EST

Mumbai, Baltimore, November 21, 2023: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration for.

South africaUnited statesShweta munjalAsia pacificLupin limitedBiotechnology pharmaceuticalsDrug administrationCorporate communications sustainabilityUnited states foodAbbreviated new drug applicationDapagliflozin tabletsLatin americaMiddle eastGreat placeGlobal head

Lupin : November 21, 2023 Lupin Receives Approval from U S FDA for Pitavastatin Tablets -November 21, 2023 at 05:26 am EST

Mumbai, Baltimore, November 21,2023: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its.

United statesSouth africaAsia pacificShweta munjalLupin limitedKowa companyCorporate communications sustainabilityBiotechnology pharmaceuticalsDrug administration united statesUnited states foodDrug administrationAbbreviated new drug applicationPitavastatin tabletsLatin americaMiddle eastGreat place

vimarsana © 2020. All Rights Reserved.